Report of Foreign Issuer (6-k)
October 25 2019 - 6:01AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE
SECURITIES EXCHANGE ACT OF 1934
For the month of, October 2019
Commission File Number 001-37652
Midatech Pharma PLC
(Translation of registrant’s name
into English)
Oddfellows House,
19 Newport Road,
Cardiff, CF24 0AA, United Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x Form
40-F o
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
SUBMITTED HEREWITH
Attached to the Registrant’s Form 6-K filing for the month
of October 2019, and incorporated by reference herein, is:
|
|
|
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press release, dated October 24, 2019 entitled
“Midatech's
MTX110 Receives Orphan Designation for DIPG”
|
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
|
|
Midatech Pharma PLC
|
|
|
|
|
|
|
|
|
Date: October 24, 2019
|
|
|
|
By:
|
|
/s/ Stephen Stamp
|
|
|
|
|
|
|
|
|
Stephen Stamp
Chief Financial Officer
|
Exhibit Index
|
|
|
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press release, dated October 24, 2019 entitled
“Midatech's
MTX110 Receives Orphan Designation for DIPG”
|
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Apr 2023 to Apr 2024